What this means
This review gathers what is known about how nerve cells rebuild their coating after injury. It does not test a new treatment, and it suggests future treatments may need to be combined.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- A review of earlier research, no new tests
- Kind of research
- A summary of earlier studies
The science
- Original title
- Myelination and Remyelination in Peripheral Nerve Injury: Mechanisms, Regulation, and Therapeutic Perspectives.
- Authors
- Huang LX, Sun T, Zhao YB et al.
- Journal
- MedComm
- Published
- Oct 13, 2026
- Study type
- Review
- PMID
- 42865824 ↗
Abstract
Peripheral nerve injury (PNI) affects 13-23 individuals per 100,000 annually, and functional recovery hinges on faithful remyelination of regenerating axons by Schwann cells (SCs). This review integrates the complete molecular logic governing the transition from injury-induced SC plasticity to mature myelin regeneration. The hierarchical transcriptional program-from SOX10 pioneer factor engagement through OCT6-mediated promyelinating transition to KROX20/EGR2-driven activation of compact myelin genes-and the instructive role of axonal Neuregulin-1 Type III signaling are dissected. Wallerian degeneration via the NMNAT2-SARM1-mediated axon degeneration cascade, c-JUN-dependent SC reprogramming, and the epigenetic and noncoding RNA mechanisms that re-engage myelination are examined. The immune microenvironment is considered as a temporally layered network in which macrophage polarization, macrophage-to-myofibroblast transition, and regulatory T cell activity coordinate the transition from inflammation to repair. Finally, this review critically evaluates emerging therapeutic strategies-including Neuregulin-1 supplementation, SC transplantation, nerve guidance conduits, electrical stimulation, and senolytic clearance of aged SCs-and argues that rationally sequenced combination therapies will be required to achieve transformative improvements in functional recovery after severe PNI. This review provides a mechanistic roadmap for designing next-generation regenerative strategies aimed at restoring saltatory conduction.
Huang LX, Sun T, Zhao YB et al. Myelination and Remyelination in Peripheral Nerve Injury: Mechanisms, Regulation, and Therapeutic Perspectives. MedComm. 2026. doi:10.1002/mco2.71019. PMID: 42865824. https://pubmed.ncbi.nlm.nih.gov/42865824/
Related research
A drug pair tested in people with fatty liver disease and scarring
In this small trial, more people on dasatinib plus quercetin had liver scarring improve than those on placebo. The trial was small, and it does not show the drugs are safe or work for everyone.
Old, stuck cells may sometimes help cancer resist treatment
This review looks at how cells that stop dividing after cancer treatment might sometimes help tumors survive. The authors say these cells play a role only in some cases, not in every case.
How cancer treatment may age the heart and blood vessels in breast cancer patients
This review looks at how cancer treatments can leave some cells stuck in an aging state that may harm the heart. It does not prove this process causes heart damage, since other factors can also play a part.
A tea plant root extract killed aging skin cells in a lab dish
Researchers tested a tea root extract on human skin cells that had been made old in a dish. The extract killed more of the old cells than normal ones, and it also cut some inflammation signals. This does not show the extract works in people, because the tests were done in cells and skin samples.
Cell aging after cancer treatment may help or hurt tumour growth
This paper is a review of earlier research on aged cells and cancer. It says these cells may either slow or speed up tumour growth.
Aging immune cells may drive Alzheimer's and Parkinson's, a review says
This review pulls together earlier studies on aging immune cells and brain disease. It suggests these cells may be a target for future treatments, but it does not prove this.
See all research on Senolytics →